Efalizumab-induced aseptic meningitis [15]

British Journal of Dermatology

Volumn 156, Issue 1, 2007, Pages 189-191

  Kluger, N ^a   Girard, C ^a   Gonzalez, V ^a   Guillot, B ^a   Bessis, D ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; LEVONORGESTREL; MIFEPRISTONE; MISOPROSTOL;

ADULT; ASEPTIC MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DRUG INDUCED ASEPTIC MENINGITIS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; GENERAL CONDITION IMPROVEMENT; GRAVES DISEASE; HEADACHE; HUMAN; LETTER; PHONOPHOBIA; PHOTOPHOBIA; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SYMPTOM;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MENINGITIS, ASEPTIC; PSORIASIS;

EID: 33845532577     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07594.x     Document Type: Letter

References (5)

1. Leonardi CL. Efalizumab in the treatment of psoriasis. Dermatol Ther 2004; 17:393-400.
2. Scheinfeld N. Efalizumab: a review of events reported during clinical trials and side effects. Expert Opin Drug Saf 2006; 5:197-209.
3. Marotte H, Charrin JE, Miossec P. Infliximab-induced aseptic meningitis. Lancet 2001; 358:1784.
4. Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med 1999; 159:1185-94.
5. Tian L, Kilgannon P, Yoshihara Y et al. Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18. Eur J Immunol 2000; 30:810-18.